Lifestyle Advises Sent Via Email in Attempt of Improving A1C in DM2 Patients
NCT ID: NCT03168633
Last Updated: 2017-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2015-07-31
2017-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This trial focuses on delivering these reminders, via email, in attempt to improve the patients glycemic control (measured in Hemoglobin A1C)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reinforcement Learning in Diabetes Mellitus Trial
NCT04473326
Assessing Home Food Environment and Diabetes Self-management Among Adult Type 2 Diabetes Patients
NCT03039569
The Effects of Short Message Notifications on Middle-Aged Diabetic Patients
NCT04733612
Diabetes Risk Education and Communication Trial
NCT03283657
Effect of Motivation Text Messages on Diabetes Patients
NCT03167866
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Furthermore, the patients were sent a questionnaire every other week which they were asked to actively reply to.
Each participating patient was monitored for 6 months, during this time he/she was sent 12 web-based information pages.
During the course of the study, information regarding the patients' glycemic control (in the form of HgA1c levels) was collected.
Additional variables (age, sex, BMI, time passed since diagnosed with DM2) were collected and used for statistical comparison.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients receiving emails
Diagnosed DM2 patients who meet inclusion criteria. the patients will receive emails containing information about DM2 as a method of reminding patients of the importance of adjusting post diagnosis life-style changes.
web-based DM2 information pages
web-based DM2 information pages
Each email will include information on one of the following topics:
1. The importance of physical activity
2. Correct nutrition
3. The importance of adhering to medication regimens.
Emails will be either positive (e.g., the importance of good nutrition, and what constitutes good nutrition) or negative (e.g., the risks of not adhering to medications).
The information will be provided by different approaches: medical research results, practical tips, patient testimonies.…
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
web-based DM2 information pages
Each email will include information on one of the following topics:
1. The importance of physical activity
2. Correct nutrition
3. The importance of adhering to medication regimens.
Emails will be either positive (e.g., the importance of good nutrition, and what constitutes good nutrition) or negative (e.g., the risks of not adhering to medications).
The information will be provided by different approaches: medical research results, practical tips, patient testimonies.…
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age over 18.
3. Diagnosis of diabetes type 2.
4. HbA1c over 7%
5. Self-admitted less than optimal adherence to physical activity, diet or medications or computer-recorded less than 80% adherence to medication purchase.
6. Able to read Hebrew
7. Uses Email account that is actively read at least twice weekly.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rambam Health Care Campus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Irit Hochberg, MD
Role: PRINCIPAL_INVESTIGATOR
Rambam Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0456-14-RMB CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.